Current Gene Therapy

Ignacio Anegon
Director INSERM UMR 1064-Center for Research in Transplantation and Immunology
CHU de Nantes. 30, boulevard
Nantes
France

Back

Building Better Chimeric Antigen Receptors for Adoptive T Cell Therapy

Volume:10   Issue:2
Pp: 77-90
John S. Bridgeman, Robert E. Hawkins, Andreas A. Hombach, Hinrich Abken and David E. Gilham
DOI: 10.2174/156652310791111001

Order Reprints Order Eprints

Effect of Administration Route on the Biodistribution and Shedding of Replication-Deficient AAV2: A Qualitative Modelling Approach

Volume:10   Issue:2
Pp: 91-106
Esther F.A. Brandon, Harm P.H. Hermsen, Jan C.H. van Eijkeren and Birgitte Tiesjema
DOI: 10.2174/156652310791111047

Order Reprints Order Eprints

Effect of Administration Route on the Biodistribution and Shedding of Replication-Deficient HAdV-5: A Qualitative Modelling Approach

Volume:10   Issue:2
Pp: 107-127
Birgitte Tiesjema, Harm P.H. Hermsen, Jan C.H. van Eijkeren and Esther F.A. Brandon
DOI: 10.2174/156652310791111038

Order Reprints Order Eprints

siRNA Delivery Using Nanocarriers – An Efficient Tool for Gene Silencing

Volume:10   Issue:2
Pp: 139-155
Bharat Khurana, Amit K. Goyal, Abhishek Budhiraja, Daisy Arora and Suresh P. Vyas
DOI: 10.2174/156652310791111010

Order Reprints Order Eprints

Gene Therapy for Acute Liver Failure

Volume:10   Issue:2
Pp: 156-166
Chuan-Long Zhu, Yu-Wen Li and Ren-Tao Gao
DOI: 10.2174/156652310791111029

Order Reprints Order Eprints